CHANGJIANG Pharmaceutical Group

Website of the Group : www.cjyyjt.com

The CHANGJIANG Pharmaceutical Group has built a complete pharmaceutical industry chain integrating the standardized base of medicinal materials, high-tech Chinese medicine production, new-type pharmaceutical capsule production, pharmaceutical logistics network, and chain operation platform. There are 3 pharmaceutical industrial parks under its jurisdiction, namely:

1. Changjiang Pharmaceutical Public Security Industrial Park:

Hubei Changjiangyuan Pharmaceutical Co., Ltd.

Hubei Changjiangfeng Pharmaceutical Co., Ltd.

Hubei Changjiang Pharmacy Chain Co., Ltd.

2. Changjiang Pharmaceutical Yunyang Industrial Park:

Hubei Changjiang Star Pharmaceutical Co., Ltd.

Hubei Xinfeng Pharmaceutical Co., Ltd.

Hubei Yongruiyuan Pharmaceutical Co., Ltd.

Hubei Huayuan Health Industry Co., Ltd.

3. Changjiang Pharmaceutical Shishou Industrial Park:

Hubei Changjiang Star Pharmaceutical Co., Ltd. Shishou Branch

4. Hubei Jindi Pharmaceutical Co., Ltd.

5. Chinese Medicine Technology R&D Center

Hubei Mingyuehe Pharmaceutical Technology Co., Ltd.

6. Jingzhou Jinfeng Pharmaceutical Development Co., Ltd.

The National Marketing Center in Wuhan has helped the development of the group. In 2019, the Group's sales of 3.3 billion yuan and 140 million yuan in tax revenue.

As a company with a sense of social responsibility, Changjiang Pharmaceutical will always take the instructions of General Secretary Xi Jinping and the Party Central Committee as an action guide for corporate development, and integrate the fulfillment of social responsibilities into the company’s development strategy, persevering, in this great era to undertake more missions and responsibilities.

Changjiang Pharmaceutical has successfully landed on the New Third Board on August 8, 2016, and its current market value is nearly 4 billion yuan. At present, Changjiang Pharmaceutical is actively preparing to transfer to the market. Changjiang Pharmaceutical's achievements in industrial poverty alleviation and financial poverty alleviation have been highly affirmed by the China Securities Regulatory Commission, and as an advanced model of the China Securities Regulatory Commission for poverty alleviation, it is given priority to receive listing guidance. The Central Organization Department, Xinhua News Agency, CCTV and other central media have paid great attention to Changjiang Pharmaceutical. Xinhua News Agency’s press release, CCTV News Channel, Central One, and News Network have reported on Changjiang Pharmaceutical’s industrial and financial poverty alleviation achievements for three times. In 2020, innovation and high-quality development are the company's main theme.

In the future, Changjiang Pharmaceutical will form a large health enterprise platform for the entire pharmaceutical industry chain with the core business of the modern traditional Chinese medicine health industry, medicinal capsules, plant functional products, pharmaceutical modern intelligent logistics and pharmaceutical chain retail.